Ambrx Biopharma American Stock Filter Stocks by Fundamentals
AMAMDelisted Stock | USD 15.73 0.71 4.73% |
Ambrx Biopharma American fundamentals help investors to digest information that contributes to Ambrx Biopharma's financial success or failures. It also enables traders to predict the movement of Ambrx Stock. The fundamental analysis module provides a way to measure Ambrx Biopharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ambrx Biopharma stock.
Ambrx |
Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
All Next | Launch Module |
Ambrx Fundamentals
Return On Equity | -0.37 | |||
Return On Asset | -0.19 | |||
Operating Margin | (483.51) % | |||
Current Valuation | 1.56 B | |||
Shares Outstanding | 63.29 M | |||
Shares Owned By Insiders | 2.09 % | |||
Shares Owned By Institutions | 97.91 % | |||
Number Of Shares Shorted | 1.16 M | |||
Price To Earning | 0.19 X | |||
Price To Book | 7.31 X | |||
Price To Sales | 432.96 X | |||
Revenue | 4.09 M | |||
Gross Profit | 7.4 M | |||
EBITDA | (61.75 M) | |||
Net Income | (67.06 M) | |||
Cash And Equivalents | 110.89 M | |||
Cash Per Share | 2.87 X | |||
Total Debt | 11.98 M | |||
Debt To Equity | 0.09 % | |||
Current Ratio | 4.70 X | |||
Book Value Per Share | 3.85 X | |||
Cash Flow From Operations | (57.7 M) | |||
Short Ratio | 1.21 X | |||
Earnings Per Share | 0.42 X | |||
Price To Earnings To Growth | (0.15) X | |||
Target Price | 28.5 | |||
Number Of Employees | 87 | |||
Beta | -2.36 | |||
Market Capitalization | 1.77 B | |||
Total Asset | 146.98 M | |||
Retained Earnings | (291.63 M) | |||
Working Capital | 73.92 M | |||
Z Score | 85.23 | |||
Net Asset | 146.98 M |
About Ambrx Biopharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ambrx Biopharma American's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ambrx Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ambrx Biopharma American based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in Ambrx Stock
If you are still planning to invest in Ambrx Biopharma American check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ambrx Biopharma's history and understand the potential risks before investing.
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |